ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

Injectable Contraceptive

Injectable Contraceptive Further Considerations Iris Kapil A NUMBER of articles have appeared in EPW during the past year and a half on the international controversy over the injectable contraceptive. Padma Prakash, in 'Retreat on Depo-Provera?1 reported and endorsed a decision by the United States Food and Drug Administration's Board of Inquiry to recommend against approval for Depo- Provera for use as a contraceptive. Depo- Provera (medroxyprogesterone or DMPA) is the brandname of one, but not the only, three-month injectable contraceptive available for use. Another, NET-EN (norethin- drone enanthate), has been, and continues to be, tested and evaluated in India and elsewhere. NET-EN is now widely used in many countries.

To read the full text Login

Get instant access

New 3 Month Subscription
to Digital Archives at

₹826for India

$50for overseas users

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top